Policy Interventions to Enhance Medical Care for People With Obesity in the United States-Challenges, Opportunities, and Future Directions.
James René JolinMinsoo KwonElizabeth BrockJonathan ChenAisha KokanRyan MurdockFatima Cody StanfordPublished in: The Milbank quarterly (2024)
Policy Points Health policymakers have insufficiently addressed care for people with obesity (body mass index ≥ 30 kg/m 2 ) in the United States. Current federal policies targeting obesity medications reflect this unfortunate reality. We argue for a novel policy framework to increase access to effective obesity therapeutics and care, recognizing that, though prevention is critical, the epidemic proportions of obesity in the United States warrant immediate interventions to augment care. Reducing barriers to and improving the quality of existing anti-obesity medications, intensive behavioral therapy, weight management nutrition and dietary counseling, and bariatric surgery are critical. Moreover, to ensure continuity of care and patient-clinician trust, combating physician and broader weight stigma must represent a central component of any viable obesity care agenda.
Keyphrases
- weight loss
- healthcare
- weight gain
- insulin resistance
- metabolic syndrome
- bariatric surgery
- body mass index
- high fat diet induced
- type diabetes
- public health
- quality improvement
- physical activity
- palliative care
- mental health
- pain management
- stem cells
- emergency department
- adipose tissue
- primary care
- affordable care act
- skeletal muscle
- social media
- risk assessment
- drug delivery
- hepatitis c virus
- small molecule
- depressive symptoms
- mesenchymal stem cells
- cancer therapy
- hiv aids
- replacement therapy
- antiretroviral therapy
- health promotion